Under30CEO on MSN
SAFEs vs convertible note: Which is right for a pre-seed round
You finally have investor interest. A couple of angels like the idea, one says “We usually do SAFEs,” another asks if you’re ...
Calgary, Alberta / October 15, 2025 –TheNewswire -Credissential Inc. (“Credissential” or the “Company”) (CSE: WHIP), a vertically integrated AI software development companyis pleased to announce a non ...
The Details: IREN announced a private offering of ordinary shares in order to fund the repurchase of its existing 2029 convertible notes and existing 2030 convertible notes. IREN also announced its ...
NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- IREN Limited (IREN) (“IREN”) today announced its intention to commence a registered direct offering of ordinary shares (the “Offering”) to a limited number ...
For many early-stage startups, choosing between a convertible note and a SAFE (Simple Agreement for Future Equity) is one of the first critical legal and strategic financing decisions. While both ...
The Company has granted the initial purchasers of the Convertible Notes an option to purchase, for settlement within a 7-day period beginning on, and including the date on which the Convertible Notes ...
WATSONVILLE, Calif.--(BUSINESS WIRE)--Granite Construction Incorporated (NYSE: GVA) (“Granite”) today announced the pricing of its previously announced offering of $325 million aggregate principal ...
MIDLAND, Texas--(BUSINESS WIRE)--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by ...
MINNEAPOLIS, July 28, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today ...
Hosted on MSN
TeraWulf proposes a $500 million private offering of convertible senior notes to fund Google backed AI venture
Bitcoin miner TeraWulf on Wednesday revealed plans to offer $500 million in convertible senior notes through a private offering. The principal amount will be due by 2032 and will be offered to persons ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has entered into separate, privately negotiated exchange agreements with a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results